New England Journal of Medicine· 2019Q1
Hepatocellular Carcinoma
- 4,690citations
- Q1SCImago
- 2019year
Short summary
Hepatocellular carcinoma (HCC), the most common primary liver cancer and fourth most common tumor globally, is primarily driven by underlying liver diseases like cirrhosis, hepatitis B/C, or NASH, which limit treatment effectiveness.
AI-generated from the title and abstract; the full text is not read.
Key points
- Primary liver cancer is the fourth most common tumor globally.
- Hepatocellular carcinoma (HCC) is the main type of primary liver cancer.
- Underlying liver disease (cirrhosis, hepatitis B/C, NASH) is the primary context for HCC development.
- Existing liver disease compromises the effectiveness of HCC treatments.
AI-generated from the title and abstract; the full text is not read.
Abstract
Primary liver cancer is the fourth most common tumor worldwide. Hepatocellular carcinoma occurs mainly in the context of cirrhosis, hepatitis B or C virus infection, or nonalcoholic steatohepatitis. Underlying liver disease limits therapeutic efficacy.
The authors' abstract, as published at the source. New England Journal of Medicine, 2019 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Epidemiology
EpidemiologyMedicine